The March of Dimes Foundation, or the March of Dimes, is a non-profit organization headquartered in Arlington, Virginia, focused on the health of pregnant women and infants in the US. Former United States president Franklin Delano Roosevelt founded the March of Dimes, then called the National Foundation for Infantile Paralysis, in 1938 to address polio. Polio is a viral illness that infects the spinal cord and may lead to paralysis. Roosevelt contracted polio in 1921, which left him permanently paralyzed from the waist down. During the 1960s, after scientists introduced polio vaccines, March of Dimes shifted its focus to prevent preterm birth and birth defects. As a non-profit organization, March of Dimes provides community service, funds for research, and efforts to educate the public about preterm birth and birth defects. While March of Dimes’ original goal was to help reduce the spread of polio in the US, it was also one of the first organizations to lead a campaign to prevent birth defects and infant mortality.

The Vaginal Microbiome Consortium, or the VMC, established in 2007, consists of a group of researchers, clinicians, statisticians, and geneticists who study the impact of the vaginal microbiome on women’s health. Virginia Commonwealth University in Richmond, Virginia operates the VMC. The United States National Institutes of Health, or the NIH, funds the VMC’s ongoing project called the Vaginal Microbiome Project. Thousands of women have contributed samples for use in research studies by the VMC, which its members have used to research the communities of microorganisms that live in the vagina. A balanced vaginal microbiome can decrease the risk of preterm birth and sexually transmitted infections, or STIs, and pelvic diseases, which helps support women’s health. Researchers can use the VMC’s findings to develop genetic sequence testing for pregnant women to predict preterm birth, which accounted for 10.4 percent of live births in the United States in 2023. The VMC’s research in reproductive health has allowed physicians to prepare birth and treatment plans that improve maternal and infant health and survival.

In April 2017, Alan Flake and colleagues published “An Extra-Uterine System to Physiologically Support the Extreme Premature Lamb,” hereafter “An Extra-Uterine System,” in the journal Nature Communications. “An Extra-Uterine System” reports on the development and testing of an artificial uterus system to keep alive prematurely born animals. Prematurity, or birth prior to thirty-seven weeks of gestational development, is the global leading cause of death in children under the age of five years. The artificial uterus technology, which the authors call the Biobag, is a flexible, sealable container. It’s filled with fluid and nutrients, which replicate the environment of a uterus, the organ where a fetus typically develops. Flake and colleagues showed that their Biobag technology could keep eight premature fetal lambs alive for up to four weeks. “An Extra-Uterine System” provoked discussion among scientists and the public about the possible use of the technology to improve survival rates for premature infants and the ethics of possible future uses of the technology.